Articoli di riviste: "Psychiatric comorbidities"

1

Şahin Cankurtaran, Eylem. "Psychiatric comorbidities in spondyloartrities". Ulusal Romatoloji Dergisi 12, n. 2 (1 dicembre 2020): 67–72. http://dx.doi.org/10.4274/raed.galenos.2020.s109.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Reardon, Claudia L. "Psychiatric Comorbidities in Sports". Neurologic Clinics 35, n. 3 (agosto 2017): 537–46. http://dx.doi.org/10.1016/j.ncl.2017.03.007.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Josephson, Colin B., e Nathalie Jetté. "Psychiatric comorbidities in epilepsy". International Review of Psychiatry 29, n. 5 (6 luglio 2017): 409–24. http://dx.doi.org/10.1080/09540261.2017.1302412.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

4

Baskin, S. "Psychiatric comorbidities in migraine". Journal of the Neurological Sciences 357 (ottobre 2015): e457. http://dx.doi.org/10.1016/j.jns.2015.09.145.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Buckley, P. F., B. J. Miller, D. S. Lehrer e D. J. Castle. "Psychiatric Comorbidities and Schizophrenia". Schizophrenia Bulletin 35, n. 2 (14 novembre 2008): 383–402. http://dx.doi.org/10.1093/schbul/sbn135.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Araz Altay, Mengühan, Işık Görker, Begüm Demirci Şipka, Leyla Bozatlı e Tuğçe Ataş. "Attention Deficit Hyperactivity Disorder and Psychiatric Comorbidities". Eurasian Journal of Family Medicine 9, n. 1 (31 marzo 2020): 27–34. http://dx.doi.org/10.33880/ejfm.2020090104.

Testo completo

Abstract (sommario):

Aim: This study aims to obtain current information on the clinical features of attention deficit hyperactivity disorder cases, comorbid psychiatric disorders and psychiatric drug use. Methods: All patients between the ages of 6 and 18 years who were admitted to our outpatient clinic and diagnosed with attention deficit hyperactivity disorder were included in the study. The files of the patients were examined and their demographic characteristics, symptoms, psychiatric diagnoses and drug profiles were recorded. The pattern of the psychiatric disorders accompanied by attention deficit hyperactivity disorder cases and the differences according to age and gender were analyzed. The differences were determined in patients with psychiatric comorbidity compared to those without. Result: The mean age of the 777 patients included in the study was 11.1±2.94 and 76.6% were boys. 60.9% of attention deficit hyperactivity disorder patients had comorbid psychiatric disorders. The most common psychiatric comorbidities were specific learning disability (23.6%), oppositional defiant disorder (12.9%) and conduct disorder (12.1%). There was no difference between the genders in terms of the incidence of psychiatric comorbidities. The rate of psychiatric comorbidity was significantly higher in adolescents than in children. A psychotropic medication was used in 86.4% of the cases and psychotropic polypharmacy was present in 31.5%. The rate of polypharmacy was significantly higher in the group with psychiatric comorbidity. Conclusion: Attention deficit hyperactivity disorder is frequently accompanied by other psychiatric disorders and the psychiatric comorbidity leads to a more complicated clinical profile. Approximately one-third of attention deficit hyperactivity disorder patients have psychiatric polypharmacy and these patients should be carefully monitored. Primary care physicians who are frequently confronted with attention deficit hyperactivity disorder cases should be careful about psychiatric comorbidities. Keywords: Child psychiatry, attention deficit hyperactivity disorder, mental disorders, Family practice

Gli stili APA, Harvard, Vancouver, ISO e altri

7

Silić, Ante. "Somatic Comorbidities in Psychiatric Patients". Cardiologia Croatica 12, n. 5-6 (giugno 2017): 275–81. http://dx.doi.org/10.15836/ccar2017.275.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Stanculete, M. F., e D. L. Dumitrascu. "Psychiatric Comorbidities in IBS Patients". Journal of Psychosomatic Research 85 (giugno 2016): 81. http://dx.doi.org/10.1016/j.jpsychores.2016.03.201.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Im-Bolter, Nancie, e Nancy J. Cohen. "Language Impairment and Psychiatric Comorbidities". Pediatric Clinics of North America 54, n. 3 (giugno 2007): 525–42. http://dx.doi.org/10.1016/j.pcl.2007.02.008.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Kao, Chi-Han, Shuu-Jiun Wang, Chia-Fen Tsai, Shih-Pin Chen, Yen-Feng Wang e Jong-Ling Fuh. "Psychiatric comorbidities in allodynic migraineurs". Cephalalgia 34, n. 3 (18 settembre 2013): 211–18. http://dx.doi.org/10.1177/0333102413505238.

Testo completo

Abstract (sommario):

Objectives To evaluate the prevalence and the association of psychological disturbance in migraine patients with allodynia. Methods We recruited 434 migraine patients from an outpatient clinic. The participants completed three self-administered questionnaires, including a headache questionnaire, an allodynia symptoms checklist, and the Hospital Anxiety and Depression Scale (HADS). Results Among the migraineurs, 48.4% participants reported allodynia. The HADS total score (15.5 ± 7.8 vs. 13.7 ± 8.5, p = 0.022) and anxiety subscore (9.1 ± 4.5 vs. 7.6 ± 4.7, p = 0.001) were higher in migraineurs with allodynia than in those without allodynia. The anxiety subscore in patients with moderate to severe allodynia, mild allodynia, and no allodynia were 10.0 ± 4.5, 8.4 ± 4.3, and 7.6 ± 4.7 ( p < 0.001, by one-way analysis of variance). Among patients with moderate to severe allodynia, there was a trend of higher depression subscore (7.1 ± 4.0, p = 0.059) than those with no (6.1 ± 4.4) or mild allodynia (5.8 ± 4.0). In a regression model, the presence of allodynia is an independent risk factor for clinically significant anxiety. Moderate to severe allodynia is an independent risk factor for clinically significant depression. Conclusions In migraineurs, the severity of cutaneous allodynia was associated with their mood status, especially anxiety.

Gli stili APA, Harvard, Vancouver, ISO e altri

11

King, Bryan H. "Psychiatric comorbidities in neurodevelopmental disorders". Current Opinion in Neurology 29, n. 2 (aprile 2016): 113–17. http://dx.doi.org/10.1097/wco.0000000000000299.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

Miguel-Puga, Adán, Gabriel Villafuerte e Oscar Arias-Carrión. "Psychiatric comorbidities in movement disorders". International Review of Psychiatry 29, n. 5 (6 luglio 2017): 516–26. http://dx.doi.org/10.1080/09540261.2017.1322043.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

El-Ghonemy, Soheir H., Haitham H. Salem, Marwa A. El-Missiry, Reem H. El-Ghamry e Yasser S. Mukhtar. "Myasthenia gravis and psychiatric comorbidities". Middle East Current Psychiatry 23, n. 2 (aprile 2016): 99–105. http://dx.doi.org/10.1097/01.xme.0000481469.56478.b0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Minen, Mia Tova, Olivia Begasse De Dhaem, Ashley Kroon Van Diest, Scott Powers, Todd J. Schwedt, Richard Lipton e David Silbersweig. "Migraine and its psychiatric comorbidities". Journal of Neurology, Neurosurgery & Psychiatry 87, n. 7 (5 gennaio 2016): 741–49. http://dx.doi.org/10.1136/jnnp-2015-312233.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Kuczynski, Evelyn. "Psychiatric comorbidities in mental retardation". Revista Debates em Psiquiatria Ano 5 (1 dicembre 2015): 7–11. http://dx.doi.org/10.25118/2236-918x-5-6-2.

Testo completo

Abstract (sommario):

Retardo mental (RM) é uma condição extremamente heterogênea em sua etiologia, definida como grupo por um funcionamento adaptativo e intelectual abaixo da média, cujo surgimento ocorre antes dos 18 anos. A ocorrência de vários transtornos mentais é mais comum nesse grupo do que na população geral. Ainda que sejam essencialmente os mesmos transtornos incidindo nesses indivíduos com RM, sua apresentação clínica pode variar em função das contingências pessoais e habilidades linguísticas do indivíduo afetado, o que pode mascarar a sintomatologia comportamental francamente observável.

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Smitherman, Todd A., Jeanetta C. Rains e Donald B. Penzien. "Psychiatric comorbidities and migraine chronification". Current Pain and Headache Reports 13, n. 4 (14 luglio 2009): 326–31. http://dx.doi.org/10.1007/s11916-009-0052-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Kanner, Andres M., Andrey Mazarati e Matthias Koepp. "Biomarkers of Epileptogenesis: Psychiatric Comorbidities (?)". Neurotherapeutics 11, n. 2 (aprile 2014): 358–72. http://dx.doi.org/10.1007/s13311-014-0271-4.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

Moghalu, Odinachi, James Hotaling e Alexander Pastuszak. "Psychiatric Comorbidities and Sexual Health". Current Sexual Health Reports 12, n. 3 (18 luglio 2020): 91–100. http://dx.doi.org/10.1007/s11930-020-00264-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Charfi, N., S. Daoud, N. Farhat, M. Maâlej Bouali, L. Zouari, N. Zouari, J. Ben Thabet, M. Damak, C. Mhiri e M. Maalej. "Prevalence of psychiatric comorbidities in epilepsy". European Psychiatry 41, S1 (aprile 2017): S470. http://dx.doi.org/10.1016/j.eurpsy.2017.01.536.

Testo completo

Abstract (sommario):

IntroductionEpilepsy is a chronic disease defined as a brain disorder, characterized by a predisposition to present seizures, generating cognitive, psychological, and social consequences.ObjectiveTo determine the prevalence of psychiatric comorbid disorders in patients with epilepsy (PWEs) and its associated factors.MethodsWe conducted a cross-sectional study involving 30 PWEs who were treated in the neurology department of Habib Bourguiba Hospital in Sfax, Tunisia. We used the Mini International Neuropsychiatric Interview for the diagnosis of Axis I psychiatric disorders.ResultsThe half of patients had psychiatric comorbidities: 4 had major depressive disorder (MDD), 2 had MDD with generalized anxiety disorder, 4 had MDD with social phobia, 1 had bipolar disorder type I, 1 had panic disorder, 1 had agoraphobia and 2 had generalized anxiety disorder.Twenty-five PWEs had seizure-onset below 30 years old and among them, 40% had psychiatric comorbidities. Among patients who had seizure-onset above 30 years old, none had psychiatric comorbidities. Psychiatric comorbidities were found in 71.5% of patients with seizure frequency >2 per year. Psychiatric comorbidities were more common in patients with generalized seizures compared to whom with partial seizures (53% versus 45%). It was also more common in patients treated with polytherapy compared to whom with monotherapy (64% versus 37.5%).ConclusionThe prevalence of psychiatric comorbidities is relatively high among PWEs. The most frequent diagnoses found were mood and anxiety disorders. It is very important to identify them and treat them to enhance seizure control.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Oliveira, P., M. Coroa, N. Madeira e V. Santos. "Sex differences in psychiatric inpatients: Demographics, psychiatric diagnoses and medical comorbidities". European Psychiatry 41, S1 (aprile 2017): S698. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1231.

Testo completo

Abstract (sommario):

ObjectivesThere are few published studies on the relationship between gender and psychiatric disorders. We assessed sex differences in a sample of first-admission psychiatric inpatients to identify possible risk factors and targets for sex-tailored treatment interventions.MethodsA retrospective study of admissions to the psychiatry department, Coimbra hospital Universitary Centre, Portugal, in 2015 was accomplished (n = 924). The two groups were compared for demographic features, psychiatric diagnoses and medical comorbidities.ResultsMale patients were significantly younger (age average = 47.7 vs. 53.3). Differences in employment, educational, and marital statuses were found between male and female psychiatric patients. Having a degree was a protective factor for males, whereas it was a risk factor for females. Being divorced and single were both risk factors for medical co-morbidity in females. A higher proportion of men among patients hospitalized for schizophrenia (14.9 vs. 5.5%) or substance use disorder (10.3 vs. 2.1%) and a higher proportion of women among those admitted for affective disorders (43.3 vs. 25.9%), including bipolar disorder (13.4 vs. 9.0%), were found. No significant differences in duration of hospitalization between the two groups (22.8 in male vs. 22.2 days in female)ConclusionsThe differences between the two groups of inpatients were very pronounced. A better understanding of these differences may help to establish more effective treatment strategies.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Serra-Pinheiro, Maria Antonia, Isabella D'andrea-Meira, Abraão Iuri Medeiros Angelim, Fernanda Alves Fonseca e Nicolle Zimmermann. "High prevalence of psychiatric comorbidities in children and adolescents at a tertiary epilepsy center". Arquivos de Neuro-Psiquiatria 79, n. 6 (giugno 2021): 521–26. http://dx.doi.org/10.1590/0004-282x-anp-2020-0202.

Testo completo

Abstract (sommario):

ABSTRACT Background: Epilepsy is highly comorbid with psychiatric disorders and a significant amount of the morbidity related to epilepsy is in fact a result of psychiatric comorbidities. Objective: To investigate the frequency of different psychiatric comorbidities in children with refractory epilepsy. Methods: We present preliminary observational data from a series of patients (n=82) examined in the psychiatric branch of a tertiary epilepsy center in Rio de Janeiro, Brazil. Patients were classified as presenting autism spectrum disorders, mood disorders, anxiety disorders, disruptive disorders, attention deficit hyperactivity disorder (ADHD), intellectual development disorder, psychotic episode, dissociative/conversive disorders or others. We determined the frequency of each disorder, along with demographic data, medications prescribed, electroencephalogram findings and additional medical examinations and consultations. Results: The most common comorbidities in our sample were autism spectrum disorders and ADHD. Antipsychotics and selective serotonin uptake inhibitors were the most commonly prescribed psychiatric medications. Conclusions: Knowledge about the prevalence of such comorbidities may provide more targeted interventions in Psychiatry and Psychology services linked to epilepsy centers.

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Filipcic, I., I. Simunovic Filipcic, M. Rojnic Kuzman, G. Vladimir, P. Svrdlin, S. Vuk Pisk e Z. Bajic. "Chronic Somatic and Psychiatric Co-morbidities are Associated with Psychiatric Treatment Success; A Nested Cross-sectional Study". European Psychiatry 41, S1 (aprile 2017): S135. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1958.

Testo completo

Abstract (sommario):

IntroductionA rich body of literature dealt with somatic comorbidities of psychiatric illnesses. However, relatively few explored the association of somatic and psychiatric comorbidities with psychiatric treatment success.ObjectiveObjective of this analysis was to explore chronic somatic and psychiatric comorbidities association with the average number of psychiatric re-hospitalisations annually.MethodsThis cross-sectional analysis was done on the baseline data of prospective cohort study “Somatic comorbidities in psychiatric patients” started during 2016 at Psychiatric hospital Sveti Ivan, Zagreb, Croatia. We included 798 patients. Outcome was the average number of psychiatric re-hospitalisations annually since the diagnosis. Predictors were number of chronic somatic and psychiatric comorbidities. Covariates that we controlled were sex, age, BMI, marital status, number of household members, education, work status, duration of primary psychiatric illness, CGI–severity at diagnosis, treatment with antidepressants and antipsychotics.ResultsInteraction of somatic and psychiatric comorbidities was the strongest predictor of the average number of psychiatric re-hospitalisations annually (P < 0.001). Mean number of re-hospitalisations annually adjusted for all covariates, was increasing from 0.60 in patients with no chronic comorbidities, up to 1.10 in patients with ≥ 2 somatic and ≥ 2 psychiatric comorbidities.ConclusionSomatic and psychiatric comorbidities are independently associated with the psychiatric treatment success. Further studies should look at possible causal pathways between them, and interdisciplinary treatment of psychiatric patients is urgently needed.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Larion, Sebastian, Daniel P. DeCecchis, Janet M. Arnold, John A. Vanslyke e Hamid R. Tavakoli. "Psychiatric Comorbidities in Inflammatory Bowel Disease". Current Psychiatry Reviews 11, n. 2 (2 maggio 2015): 124–29. http://dx.doi.org/10.2174/157340051102150502083333.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

24

Deas, Deborah, e E. Sherwood Brown. "Adolescent Substance Abuse and Psychiatric Comorbidities". Journal of Clinical Psychiatry 67, n. 07 (15 luglio 2006): e02. http://dx.doi.org/10.4088/jcp.0706e02.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Barczi, Steven R., e Timothy M. Juergens. "Comorbidities: Psychiatric, Medical, Medications, and Substances". Sleep Medicine Clinics 1, n. 2 (giugno 2006): 231–45. http://dx.doi.org/10.1016/j.jsmc.2006.04.001.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Castillo-Carniglia, Alvaro, Katherine M. Keyes, Deborah S. Hasin e Magdalena Cerdá. "Psychiatric comorbidities in alcohol use disorder". Lancet Psychiatry 6, n. 12 (dicembre 2019): 1068–80. http://dx.doi.org/10.1016/s2215-0366(19)30222-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Lipchik, Gay L., e Donald B. Penzien. "Psychiatric comorbidities in patients with headaches". Seminars in Pain Medicine 2, n. 2 (giugno 2004): 93–105. http://dx.doi.org/10.1016/j.spmd.2004.04.003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Kallweit, Ulf, Esther Werth, Angela Seiz, Sandra Sefidan, Norbert Dahmen, Mauro Manconi, Ulrike Ehlert e Claudio L. A. Bassetti. "Psychiatric Comorbidities in Restless Legs Syndrome". Journal of Neuropsychiatry and Clinical Neurosciences 28, n. 3 (luglio 2016): 239–42. http://dx.doi.org/10.1176/appi.neuropsych.15030055.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Makani, Ramkrishna, e Tapan Parikh. "Psychiatric Comorbidities With Cyclic Vomiting Syndrome". American Journal of Psychiatry Residents' Journal 12, n. 11 (novembre 2017): 4–6. http://dx.doi.org/10.1176/appi.ajp-rj.2017.121102.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Zurowski, Mateusz, William M. McDonald, Susan Fox e Laura Marsh. "Psychiatric comorbidities in dystonia: Emerging concepts". Movement Disorders 28, n. 7 (15 giugno 2013): 914–20. http://dx.doi.org/10.1002/mds.25501.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Fogel, B., M. Bauer, S. Kendall e F. Holden. "Psychiatric comorbidities and hospitalization for mania". Biological Psychiatry 35, n. 9 (maggio 1994): 729. http://dx.doi.org/10.1016/0006-3223(94)91068-5.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

32

Jaiswal, Saurabh, e Santosh Kumar. "Psychiatric Comorbidities in Patients with Epilepsy: A Cross-sectional Study". International Journal of Advanced and Integrated Medical Sciences 2, n. 1 (2017): 24–28. http://dx.doi.org/10.5005/jp-journals-10050-10068.

Testo completo

Abstract (sommario):

ABSTRACT Introduction People with epilepsy are more likely than the general population to have comorbid psychiatric disorders that include anxiety, depression, and interictal and chronic psychoses. Even though psychiatric comorbidity is common in epilepsy, it is underrecognized and undertreated, both in specialty epilepsy centers and also in community-based services. A thorough assessment of this was sought in this study among the patients of Rohilkhand region of Uttar Pradesh (India). Materials and methods A total of 100 patients with epilepsy who visited the psychiatry outpatient clinic were recruited for this study. They were assessed in detail for the presence of comorbid psychiatric disorders on Axis 1 with the help of Structured Clinical Interview for Fourth Edition of the Diagnostic and Statistical Manual of Mental Disorders. Results Overall, it was found that a comorbidity of psychiatric disorders was present in 45% of patients with epilepsy. The frequency of cooccurrence of different types of psychiatric disorders was as follows: Mood disorders 21%, anxiety disorders 14%, and psychotic disorders 28%. Conclusion Psychiatric comorbidities were found to be a common problem in patients with epilepsy. The results of this study are in line with many different research works both in India and abroad. A proper address of this issue is important for management, better outcome, and policy making in patients with epilepsy. How to cite this article Jaiswal S, Kumar S, Sharma CS, Kuchhal A, Jaiswal A. Psychiatric Comorbidities in Patients with Epilepsy: A Cross-sectional Study. Int J Adv Integ Med Sci 2017;2(1):24-28.

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Walsh, Kelda Harris, Katherine Soe e Shivali Sarawgi. "Psychiatric Treatment and Management of Psychiatric Comorbidities of Movement Disorders". Seminars in Pediatric Neurology 25 (aprile 2018): 123–35. http://dx.doi.org/10.1016/j.spen.2017.12.002.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Simunovic Filipcic, I., F. Igor, B. Marijana, K. Matic, I. Ena, V. Antonija, L. Nikolina, D. Rudan e B. Zarko. "Somatic comorbidities are associated with poorer treatment outcome in schizophrenia spectrum disorders, independently of psychiatric comorbidities and other clinical factors". European Psychiatry 41, S1 (aprile 2017): S384. http://dx.doi.org/10.1016/j.eurpsy.2017.02.421.

Testo completo

Abstract (sommario):

IntroductionIncreased somatic morbidities in schizophrenic patients and their association with HRQoL are well documented. Less is known about their association with schizophrenia treatment outcome.ObjectiveTo explore whether the number of somatic comorbidities is associated with poorer psychosis treatment outcome independently of psychiatric comorbidities and other clinical and socio-demographic parameters.AimTo improve understanding of association of somatic morbidities on treatment outcome of schizophrenic patients.MethodsThis nested-cross-sectional study was done during 2016 at Psychiatric hospital Sveti Ivan, Zagreb-Croatia on the sample of 301 patients diagnosed with schizophrenia spectrum disorder. Outcomes were the number of psychiatric rehospitalizations since primary psychiatric diagnosis and the composite of significant improvement measured by CGI-S and the best self-rated health defined as 4th quartile of EQ-5D-5L VAS. Predictors were number of somatic and psychiatric comorbidities. By logistic regression, we controlled socio-demographic and clinical confounders.ResultsHaving two or more somatic comorbidities was significantly associated with the failure to achieve the composite of improvement. The number of somatic comorbidities was significantly associated with increase in psychiatric hospitalizations, even after the adjustment for psychiatric comorbidities and large number of clinical and socio-demographic variables.ConclusionsChronic somatic comorbidities are associated with poorer psychosis treatment outcome independently of psychiatric comorbidities and other factors. Therefore, to treat psychosis effectively it may be essential to treat chronic somatic comorbidities promptly and adequately. The integrative approach should be the imperative in clinical practice.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Radwan, Rifat Binte, e Chiro Islam Mallik. "Psychiatric comorbidities with autism spectrum disorder in an adult clinic sample". BJPsych Open 7, S1 (giugno 2021): S239. http://dx.doi.org/10.1192/bjo.2021.639.

Testo completo

Abstract (sommario):

AimsAs part of continuity, prevalence of Autism Spectrum Disorder (ASD) is nearly the same in adults as children and is associated with other comorbid psychiatric disorders that have substantial impact on their life and complex the intervention. This study aimed to examine psychiatric comorbidity in referred adult ASD patients compared to non-ASD psychiatric patients. It has been hypothesized that comorbid psychiatric disorders were higher among patients with ASD than patients without ASD.MethodIn total, 36 adults with ASD referred in the year 2019 in a psychiatric consultation center in Dhaka city were included in the study. They were derived from the case register of the center. Similar number of age and sex-matched adult psychiatric patients without ASD were selected for comparison. All patients were referred for psychiatric consultation. Socio-demographic variables were collected from the patients’ record. Diagnosis of psychiatric disorders including ASD was made by an experienced psychiatrist. It was done clinically based on all available information, examination and relevant investigations. Diagnoses were assigned according to DSM-5. Then comparisons of psychiatric disorders were made between the two patient groups.ResultThe cases were ranged from 18-41 years with the mean of 26.72 ± 6.5 years. Among them, 22 were male and 14 were female. Male-female ratio was 1.6:1. Most of the subjects received no education and were from middle income family with urban background. Mean number of comorbid psychiatric disorders was 1.92 in patients with ASD and 1.67 in patients without ASD and the difference was significant (P = 0.04). Most two frequent comorbidities among ASD patients were Obsessive Compulsive Disorder (27.77%) and Major Depressive Disorder(25%) followed by Specific Phobia(19.44%), Social Phobia and Intermittent Explosive Disorder(16.67%) for each, Attention Deficit Hyperactivity Disorder(13.89%) and Conduct Disorder(11.11%). All these disorders were significantly higher than patients without ASD. Conversely, Major Depressive Disorder (30.55%) was most frequent among the patients without ASD and that was even significantly higher than patients with ASD. Other frequent disorders like Bipolar Disorder, Schizophrenia, Generalized Anxiety Disorder and Substance Related Disorder were also higher among non-ASD patients.ConclusionThis research shows that comorbid psychiatric disorders were frequently found in patients with ASD. Subsequent broad-based studies using extensive measures of psychopathology are required to confirm these preliminary findings. Greater understanding of the presence of other psychiatric disorders in ASD patients will turn this awareness into action.

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Filipcic, I., I. Simunovic Filipcic, E. Ivezic, K. Matic, N. Tunjic Vukadinovic, S. Vuk Pisk, D. Bodor, Z. Bajic, M. Jakovljevic e N. Sartorius. "Chronic physical illnesses in patients with schizophrenia spectrum disorders are independently associated with higher rates of psychiatric rehospitalization; a cross-sectional study in Croatia". European Psychiatry 43 (giugno 2017): 73–80. http://dx.doi.org/10.1016/j.eurpsy.2017.02.484.

Testo completo

Abstract (sommario):

AbstractBackground:Increased physical morbidity in patients with schizophrenia spectrum disorders (SSDs) is well documented. However, much less is known about the association between somatic comorbidities and psychosis treatment outcomes.Subjects and methods:This cross-sectional study, nested within the larger frame of a prospective cohort study, was done in 2016 at Psychiatric Hospital Sveti Ivan, Zagreb, Croatia. Data were collected on a consecutive sample of 301 patients diagnosed with schizophrenia spectrum disorders who achieved a stable therapeutic dosage. Key outcome was the number of psychiatric rehospitalizations since diagnosis of the primary psychiatric illness. Predictors were number of physical and psychiatric comorbidities. By robust regression, we controlled different clinical, sociodemographic, and lifestyle confounding factors.Results:The number of chronic somatic comorbidities was statistically significantly associated with a larger number of psychiatric rehospitalizations, even after the adjustment for number of psychiatric comorbidities and large number of other clinical, sociodemographic, and lifestyle variables.Conclusions:Chronic somatic comorbidities are associated with higher rates of psychiatric rehospitalization independently of psychiatric comorbidities and other clinical, sociodemographic, and lifestyle factors. Therefore, to treat psychosis effectively, it may be necessary to treat chronic somatic comorbidities promptly and adequately. Chronic somatic comorbidities should be considered equally important as the SSD, and should be brought to the forefront of psychiatric treatment and research with the SSD as one entity. The integrative approach should be the imperative in clinical practice.

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Rajkumar, Ravi Philip. "Psychiatric comorbidities in dermatitis artefacta: A systematic review and meta-analysis". Cosmoderma 1 (27 settembre 2021): 49. http://dx.doi.org/10.25259/csdm_44_2021.

Testo completo

Abstract (sommario):

Dermatitis artefacta, also known as factitious or factitial dermatitis, is a rare and difficult-to-treat condition characterized by self-inflicted skin lesions. Despite the well-documented psychological disturbances that characterize this condition, little is known about the relative frequency of specific psychiatric disorders in this patient group. The current systematic review was undertaken to address this gap in our knowledge and was conducted in accordance with PRISMA guidelines. The PubMed and Scopus databases were searched using the terms “dermatitis artefacta,” “factitious dermatitis,” and “factitial dermatitis” in combination with “psychiatry,” “psychiatric diagnosis,” “psychiatric disorder,” “mental illness,” “depression,” and “anxiety.” After screening a total of 215 citations, a total of 11 papers were included in the final review. All the included studies were of low to very low quality as per the GRADE guidelines, and there was substantial heterogeneity among them (I2 = 50.4). It was observed that 46.2% of patients (95% CI: 35.4–57.4%) with dermatitis artefacta had a comorbid psychiatric disorder, with the most common diagnoses being depression, somatoform disorders, anxiety disorders, substance use disorder, and intellectual disability. About 20.1% of patients refused a psychiatric evaluation, while 40.9% reported a significant stressful life event. These results suggest that a significant proportion of patients with dermatitis artefacta suffer from psychiatric disorders, which may be related to their self-infliction of lesions either biologically or psychologically. Treatment of these disorders may lead to a partial or complete improvement in their dermatological condition. A sensitive, non-confrontational approach is essential when evaluating these patients to minimize the chances of refusal and improve patient compliance.

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Mula, Marco. "Treatment issues for psychiatric comorbidities of epilepsy". Clinical Practice 10, n. 3 (maggio 2013): 293–99. http://dx.doi.org/10.2217/cpr.13.18.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Corchs, Felipe, Juliane P. P. Mercante, Vera Z. Guendler, Domingos S. Vieira, Marcelo R. Masruha, Frederico R. Moreira, Marcio Bernik, Eliova Zukerman e Mario F. P. Peres. "Phobias, other psychiatric comorbidities and chronic migraine". Arquivos de Neuro-Psiquiatria 64, n. 4 (dicembre 2006): 950–53. http://dx.doi.org/10.1590/s0004-282x2006000600012.

Testo completo

Abstract (sommario):

BACKGROUND: Comorbidity of chronic migraine (CM) with psychiatric disorders, mostly anxiety and mood disorders, is a well-recognized phenomenon. Phobias are one of the most common anxiety disorders in the general population. Phobias are more common in migraineurs than non-migraineurs. The clinical profile of phobias in CM has never been studied. METHOD: We investigated the psychiatric profile in 56 patients with CM using the SCID I/P interview. RESULTS: Lifetime criteria for at least one mental disorder was found in 87.5% of the sample; 75% met criteria for at least one lifetime anxiety disorder and 60.7% of our sample fulfilled DSM-IV criteria for lifetime phobic avoidant disorders. Mood and anxiety scores were higher in phobic patients than in non-phobic CM controls. Number of phobias correlated with higher levels of anxiety and depression. CONCLUSION: Phobias are common in CM. Its recognition may influence its management. Early treatment may lead to better prognosis.

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Arbabi, M., M. Shirmohammadi, Z. Taghizadeh, H. Haghanni e H. Parsafar. "P01-368-Premenstrual syndrome and psychiatric comorbidities". European Psychiatry 26, S2 (marzo 2011): 370. http://dx.doi.org/10.1016/s0924-9338(11)72079-x.

Testo completo

Abstract (sommario):

ObjectivePremenstrual syndrome (PMS) is a common disorder with prevalence rate of approximately 30%; its concurrence with psychiatric symptoms will make it a disabling condition that resists usual treatment.This study was enrolled to assess the co-morbidity of PMS andpsychiatric disorders in a sample of girls with PMS compared to those without PMS.MethodThis study was conducted through a cross sectional method with 362 participants (166 with PMS and 196 healthy girls) who were selected randomly and completed the demographic questionnaire, premenstrual syndrome symptom daily record scale and the symptom checklist 90-revised (SCL-90-R).ResultsAccording to the result of the independent t test, the mean score of all the psychiatric symptoms in the PMS group was significantly higher than those in healthy group (P < 0.001). According to SCL-90-R measurement, most of the participants in the PMS group were categorized as extremely sick for somatization (44%), obsessive-compulsive (59%), depression (58.4%), anxiety (64.5%), hostility (47%) and psychoticism (69.3%); most of the participants were diagnosed as having borderline severity of disorders for interpersonal sensitivity (44.6%) and paranoid (42.8%) and most of the respondents with PMS (46.4%) were diagnosed as healthy only for phobic anxiety.ConclusionThere is a considerable relationship between PMS and different psychiatric symptoms that can complicate the diagnosis of PMS and its treatment for the health care providers. Therefore, all health care providers who are in contact with women in their reproductive age should be sensitive to mental health status in women with PMS.

Gli stili APA, Harvard, Vancouver, ISO e altri

41

MAHONEY, DIANA. "Look for Psychiatric Comorbidities in Epileptic Adults". Family Practice News 40, n. 2 (febbraio 2010): 50. http://dx.doi.org/10.1016/s0300-7073(10)70148-1.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

MAHONEY, DIANA. "Psychiatric, CNS Comorbidities More Common in Epilepsy". Clinical Psychiatry News 38, n. 5 (maggio 2010): 21. http://dx.doi.org/10.1016/s0270-6644(10)70236-8.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

Kanner, Andres M. "Psychiatric comorbidities and premature death in epilepsy". Nature Reviews Neurology 9, n. 11 (29 ottobre 2013): 606–8. http://dx.doi.org/10.1038/nrneurol.2013.214.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

Arigo, Danielle, Alicia M. Anskis e Joshua M. Smyth. "Psychiatric comorbidities in women with Celiac Disease". Chronic Illness 8, n. 1 (20 settembre 2011): 45–55. http://dx.doi.org/10.1177/1742395311417639.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Evans, Randolph W., e Noah Rosen. "Expert Opinion: Migraine, Psychiatric Comorbidities, and Treatment". Headache: The Journal of Head and Face Pain 48, n. 6 (giugno 2008): 952–58. http://dx.doi.org/10.1111/j.1526-4610.2008.01074.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Dvir, Yael, Julian D. Ford, Michael Hill e Jean A. Frazier. "Childhood Maltreatment, Emotional Dysregulation, and Psychiatric Comorbidities". Harvard Review of Psychiatry 22, n. 3 (2014): 149–61. http://dx.doi.org/10.1097/hrp.0000000000000014.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Glauser, Tracy, Daniel Santel, Melissa DelBello, Robert Faist, Tonia Toon, Peggy Clark, Rachel McCourt, Benjamin Wissel e John Pestian. "Identifying epilepsy psychiatric comorbidities with machine learning". Acta Neurologica Scandinavica 141, n. 5 (maggio 2020): 388–96. http://dx.doi.org/10.1111/ane.13216.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Guenzel, Nicholas, e Daniel J. Schober. "Psychiatric Comorbidities and BMI: An Exploratory Analysis". Issues in Mental Health Nursing 38, n. 9 (26 luglio 2017): 698–704. http://dx.doi.org/10.1080/01612840.2017.1341588.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

49

JANCIN, BRUCE. "Many Children With RLS Have Psychiatric Comorbidities". Pediatric News 45, n. 2 (febbraio 2011): 21. http://dx.doi.org/10.1016/s0031-398x(11)70033-9.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

50

Silva Junior, R. C., P. O. L. Landim, R. S. Mancio, H. H. Siqueira, B. R. Gumiero, R. M. A. Asckar, C. H. Rocha Junior, A. Ragnini e B. Rodrigues. "Epilepsy: quality of life and psychiatric comorbidities". Journal of the Neurological Sciences 357 (ottobre 2015): e157. http://dx.doi.org/10.1016/j.jns.2015.08.529.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Articoli di riviste sul tema "Psychiatric comorbidities"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili